Mathematical Modeling and Stability Analyses of Lassa Fever Disease with the Introduction of the Carrier Compartment by Akinade, Mary Oluwabunmi et al.
Mathematical Theory and Modeling                                                                                           www.iiste.org 
ISSN 2224-5804 (Paper)    ISSN 2225-0522 (Online) DOI: 10.7176/MTM 
Vol.9, No.6, 2019 
 
45 
Mathematical Modeling and Stability Analyses of Lassa Fever 
Disease with the Introduction of the Carrier Compartment 
Mary Oluwabunmi Akinade 1∗, Ayodeji Sunday Afolabi 2, Mark Eric Kimathi 3 
1. Department of Computational Mathematics, Pan African University Institute for Basic Sciences, 
Technology and Innovation (PAUSTI), P.O. Box 62000-00200, Nairobi-Kenya  
2. Department of Mathematical Sciences, Federal University of Technology Akure (FUTA), P.M.B. 704, 
Akure, Ondo State, Nigeria 
3. Department of Mathematics and Statistics, Machakos University (MKsU), P.O Box 136-90100, 
Machakos-Kenya 
* E-mail of the corresponding author: akinademary18@gmail.com 
 
Abstract 
In this paper, a new mathematical model which takes into account the human and vector populations together with 
their interactions during Lassa fever disease transmission was developed. This transmission process is denoted by 
a seven mutually exclusive compartments for the human and vector populations. The proposed model is used to 
introduce the incubation period of the disease, a period in which an infected individual is yet to be symptomatic 
but infectious however, as denoted by the carrier human compartment. This carrier compartment was critically 
examined for its short and long term effects on the spread and control of the disease. Local and global stability 
analyses of the equilibrium points of the model was carried out using the first generation matrix approach and the 
direct Lyapunov method respectively. These analyses showed that the disease free equilibrium point of the 
developed model is locally asymptotically stable but not globally asymptotically stable. It was also observed that, 
although, there exist a unique endemic equilibria for the disease, this equilibria however is not stable. Numerical 
simulations of the model were carried out by implementing the MATLAB ODE45 algorithm for solving non-stiff 
ordinary differential equations. The results of these simulations are the effects of the various model parameters on 
each compartment of the developed model. Based on the findings of this research, necessary recommendations 
were made for the applications of the model to an endemic area. 
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1. Introduction 
Lassa Fever (LF) is a fatal acute Viral Hemorrhagic fever caused by Lassa Virus (LASV). LASV belongs to the 
arena-virus family of viruses and the major host of this virus is the Mastomys (atalensis) rat specie. In addition to 
Person to person transmission, the other major form of transmission of the disease is from an infected animal(s) to 
humans. Laboratory transmission in hospitals lacking appropriate infection prevention and control measures is also 
common. The first occurrence of Lassa fever was in a town called "Lassa" in the present Borno state of Nigeria in 
1969 and this was how the name "Lassa fever" was given to the disease. The first victim of the disease was a 65 
year old female nurse who worked at the Lassa mission hospital, presently known as "Bingham University 
Teaching Hospital", in Borno state, Nigeria. Subsequently, the disease has been greatly spreading in Africa. 
Currently, there has been an outbreak of LF in many west African countries, such as Sierra Leone, Liberia, Guinea 
and Nigeria, with an increasing fatal rate. The fatality rate in symptomatic, hospitalized patients ranges from 15% 
to 20% and as high as 90% in pregnant women [10]. There has been more outbreak of LF disease in Nigeria than 
in every other countries in which the disease has ever been reported. Among the 413 confirmed Lassa fever cases 
in Nigeria between 1st day of January and the 15th day of April 2018, 114 deaths were reported [23]. 
 
The 2018 LF outbreak in Nigeria was the largest recorded outbreak of the virus with about 1,400 suspected cases 
and more than 300 confirmed cases between April and June 2018 [11]. Other incidences of Lassa fever appear to 
be in areas of eastern sierra Leone, south-eastern Guinea, and northern Liberia. [21] reported that a total of 128 
contacts, including 59 health care workers, have been line-listed and were being followed up in Liberia in June, 
2018. Two deaths were reported in this outbreak. The release also disclosed that, although LF is not new to Liberia, 
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it was a deadly viral disease that required an intervention. No outbreak of the fever has ever been recorded in CÃ´te 
d’Ivoire, Togo and Benin, though isolated cases show evidence of viral circulation of the disease in these countries. 
The most recent Lassa fever outbreak in Nigeria was between January 28 and February 3rd, 2019 with a record of 
68 new confirmed cases and 14 new deaths, making it a total of 275 confirmed cases and 57 confirmed deaths in 
the first quarter of 2019 alone [1]. Consequently, the federal government of Nigeria declared a LF outbreak in the 
country as stated in a signed statement by the Director-General of the NCDC, Dr Chikwe Ihekweazu [25]. He 
further added that this outbreak usually occur during the Nigerian dry season, ranging from January to April of 
each year. The mode of transmission of LASV is through direct contact with an infected rodent or via ingestion of 
food which has been contaminated by the droppings, such as excreta, urine, or saliva, of an infected rodent. Most 
people contract LF via anything contaminated with rat urine, faeces, blood, saliva or through eating, drinking or 
simply handling contaminated objects in the home. LF can also be transmitted via direct contact with the blood, 
urine, faeces, pharyngeal secretions or other body secretions of an infected person. 
The incubation period of Lassa fever, a period in which an infected person do not exhibit any symptom of the 
infectiousness, is a duration of 6 to 21 days from the onset of the infection. Fever, general weakness and malaise 
are usually the first symptoms to appear in symptomatic patients. Moreover, Lassa fever disease, at its symptomatic 
stage, is quite difficult to distinguish from many other diseases which cause fever, including malaria, shigellosis, 
typhoid fever, yellow fever and other viral hemorrhagic fevers. Moreover, in contrast with some other viral 
diseases, such as the Human Immune-deficiency virus (HIV), of which the Center for Disease Control and 
Prevention, [9], states specifically that it cannot be transmitted via water, saliva, tears, or sweat, due to its very 
short lifespan outside the host, LASV, however, according to the Pathogen Safety Data Sheet, [22], is stable as an 
aerosol and has a biological half-life, between 240𝐶 and 320𝐶, of 10.1 to 54.6 minutes outside host. This implies 
that contact with the secretions of an infected rodent or human over this period of time could still lead to the virus 
been transmitted. 
Although, Mastomys atalensis species complex are widely distributed in sub-Sahara Africa, the ones harboring 
Lassa virus are the autochthonous of West Africa and that is why Lassa virus still spreads only in West Africa 
Countries [16]. However, there has been a report of some Lassa fever cases being "imported" into the U.S. and 
U.K. via travelers who acquired the disease elsewhere [13]. Presently, there is no licensed vaccine or Food and 
Drug Administration approved treatment against LASV [12]. However, replication-competent attenuated vaccine, 
one of which is Ribavirin, remains the most effective treatment against the disease especially if administered during 
the early stage of the infectiousness. In addition, LF disease can be prevented by practicing good hygiene, proper 
sanitation of the environment and the use of rodent-proof containers in storing food. 
[15] investigated the prevalence of LF disease in Northern part of Edo State, Nigeria with a high rate of infection 
on contact persons. The results of their investigations showed that, to control the spread of the virus, the average 
number of new secondary infection(s) generated by a single infected individual/rodent during their infectious 
period, 𝑅0, must be brought below one. Consequently, [2] developed a mathematical model for the transmission 
of Lassa fever with isolation of infected individuals and obtained the basic reproduction number, 𝑅0. The analysis 
showed that the disease free equilibrium (DFE) is locally and globally asymptotically stable whenever the threshold 
quantity, 𝑅0, is less than unity (𝑅0 < 1). They also concluded that the endemic equilibrium point, a positive steady 
state solution when the disease persists in the population, of the model exists under certain condition. Similarly, 
[18] developed a mathematical model for the transmission of LF. This model was used to analyze the existence 
and stability of the DFE of LF disease. They, however, concluded that though the DFE is globally asymptotically 
stable (with 𝑅0 < 1), the disease will still continue to spread. 
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       Figure 1.1: Geographic Distribution of Lassa Fever in West African affected Countries, 1969-2018 [23] 
   
Subsequently, [17] modeled the transmission of Lassa fever virus between humans and rodents with control 
strategies as a six-dimensional ordinary differential equation. Stability analysis of the DFE was performed and the 
basic reproduction number obtained using the next generation operator approach. The existence of endemic 
equilibrium was further determined. The study, then, concluded that more awareness should be conducted in the 
affected areas so as to prevent more outbreaks of the disease. [3] modeled the control of LF disease using an SITR 
model. The results of their investigation showed that, though there exist an endemic equilibria for the disease, the 
disease can still be controlled by using appropriate control strategies. As an extension of this model, we introduced 
the Carrier human compartment together with new model parameters and control strategies into the previously 
existing model, as discussed below, in order to have a more realistic model which is closer to what is obtainable 
in the real life situation. 
 
2. Model Description and Formulation 
Mathematical modeling is one of the most important tools used in understanding the dynamics of disease 
transmission. In the proposed model, in order to indicate individuals with unique mutually exclusive natures, we 
considered five mutually exclusive compartments for the human population in relation to the disease status. These 
compartments are: The Susceptible 𝑆ℎ(𝑡), the Carriers 𝐶ℎ(𝑡), the Infected 𝐼ℎ(𝑡), the Treated 𝑇ℎ(𝑡) and the 
Recovered 𝑅ℎ(𝑡) human populations. For the rodent population, we considered two compartments namely: The 
Susceptible 𝑆𝑣(𝑡) and the Infected 𝐼𝑣(𝑡) vector populations. 
The susceptible human compartment is made up of members who are not yet infected but stand a chance of 
contracting the infection if exposed to an infected individual. This is mostly because they live within a community 
in which the virus exists or has been previously reported. The carrier compartment consists of individuals who 
have the infection but do not show any clinical/noticeable symptoms even though they are infectious. The infected 
human compartment is made up of individuals who are with the fully blown infection with symptomatic evidence 
i.e they have survived the 6-21 days incubation period of the disease. The treated compartment is made up of 
individuals who are not only being treated but have been isolated from the other members of the community, hence 
are not infectious. The recovered compartment is made up of individuals who have either undergone treatment and 
have now fully recovered from the infection or have recovered by their own natural immunity. 
We shall incorporate new model parameters such as: the rate of progression from the carrier class of the human 
population to the infected class to be denoted by 𝜎ℎ , contracting rate for susceptible human population via 
interaction with the carriers to be denoted by 𝛽𝑐 and the rate of recovery of the carrier class by natural immunity 
to be denoted by 𝛾1 into the existing model of [3].  
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Table 2.1: The Model State Variables 
 Variables Description  
 𝑆ℎ(𝑡)   Susceptible Human Population 
𝐶ℎ(𝑡)   Carrier Human Population 
𝐼ℎ(𝑡)   Infected Human Population  
𝑇ℎ(𝑡)   Treated Human Population 
𝑅ℎ(𝑡)   Recovered Human Population 
𝑆𝑣(𝑡)   Susceptible Vector Population 
𝐼𝑣(𝑡)   Infected Vector Population 
 
 
Table 2.2: The Model Parameters 
 Parameters   Description  
𝛼ℎ     Recruitment Rate into Susceptible Human Population  
𝜇ℎ     Natural Death Rate of Human Population 
𝜔ℎ     Rate of Loss of Immunity of Recovered Population 
𝛽𝑐     Contracting Rate for Susceptible Human Population via Interaction with the Carriers 
𝛽ℎ     Contracting Rate for Susceptible Human Population via Interaction with Infected Humans 
𝛽𝑣     Contracting rate for Susceptible Human Population via interaction with Infected Vectors 
𝛿ℎ     Disease-Induced Death Rate of Human Population 
𝜇𝑣     Natural Death Rate of Vector Population 
𝜎ℎ     Rate of Progression from Carriers to Infected Human Population 
𝛾2     Rate of Progression from Infected Human to Treated Human Population 
𝛼𝑣     Recruitment Rate into Susceptible Vector Population 
𝛿𝑣     Disease-Induced Death Rate of Vector Population 
𝜔𝑣     Rate of Progression from Susceptible Vector to Infected Vector Population 
𝛾3     Recovery Rate of Treated Human Population 
𝛾1     Rate of Recovery of the Carriers by Natural Immunity 
𝛾4     Rate of Recovery of Infected Human by Natural Immunity 
𝛽     Treatment Factor  
 
 
Model Assumptions: 
• The treated class are isolated from the remaining classes and are thus not infectious.  
• Infected Rodents do not recover throughout their entire life-time.  
• Treatment is given only to infected individuals.  
• Infected Rodents are not given any form of Rodenticide.  
• Each compartment in the model is made up of individuals or vectors with homogeneous characteristic 
(disease status).  
• Every individual, in the studied population, who has never been infected with the virus is susceptible to 
the virus.  
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Figure  2.1: Schematic flow diagram of Lassa fever transmission in human host (A) and vector host (B). 
   
Model Equations: 
 
𝑑𝑆ℎ
𝑑𝑡
= 𝛼ℎ +𝜔ℎ𝑅ℎ − (𝛽𝑐𝐶ℎ + 𝛽ℎ𝐼ℎ + 𝛽𝑣𝐼𝑣)𝑆ℎ − 𝜇ℎ𝑆ℎ (2.1) 
 
𝑑𝐶ℎ
𝑑𝑡
= (𝛽𝑐𝐶ℎ + 𝛽ℎ𝐼ℎ + 𝛽𝑣𝐼𝑣)𝑆ℎ − 𝜎ℎ𝐶ℎ − 𝛾1𝐶ℎ − 𝛿ℎ𝐶ℎ − 𝜇ℎ𝐶ℎ (2.2) 
 
𝑑𝐼ℎ
𝑑𝑡
= 𝜎ℎ𝐶ℎ − 𝛾2𝐼ℎ − 𝛾4𝐼ℎ − 𝛿ℎ𝐼ℎ − 𝜇ℎ𝐼ℎ (2.3) 
 
𝑑𝑇ℎ
𝑑𝑡
= 𝛾2𝐼ℎ − 𝛽𝛾3𝑇ℎ − (1 − 𝛽)𝛿ℎ𝑇ℎ − 𝜇ℎ𝑇ℎ (2.4) 
 
𝑑𝑅ℎ
𝑑𝑡
= 𝛾1𝐶ℎ + 𝛾4𝐼ℎ + 𝛽𝛾3𝑇ℎ − 𝜔ℎ𝑅ℎ − 𝜇ℎ𝑅ℎ (2.5) 
 
𝑑𝑆𝑣
𝑑𝑡
= 𝛼𝑣 − 𝜔𝑣𝑆𝑣 − 𝜇𝑣𝑆𝑣 (2.6) 
 
𝑑𝐼𝑣
𝑑𝑡
= 𝜔𝑣𝑆𝑣 − 𝜇𝑣𝐼𝑣 − 𝛿𝑣𝐼𝑣  (2.7) 
  
 
3. The Model Analyses 
  
3.1 The Invariant Region 
In this section, we shall define a region within which the solutions to the model are uniformly bounded as the set 
Ω1 ∈ 𝑅+
5  and Ω2 ∈ 𝑅+
2  for the human and vector populations respectively. The total human population is defined 
as 𝑁ℎ(𝑡) = 𝑆ℎ(𝑡) + 𝐶ℎ(𝑡) + 𝐼ℎ(𝑡) + 𝑇ℎ(𝑡) + 𝑅ℎ(𝑡) while that of the vector population is defined as 𝑁𝑣(𝑡) =
𝑆𝑣(𝑡) + 𝐼𝑣(𝑡). Hence, 
𝑑𝑁ℎ
𝑑𝑡
=
𝑑𝑆ℎ
𝑑𝑡
+
𝑑𝐶ℎ
𝑑𝑡
+
𝑑𝐼ℎ
𝑑𝑡
+
𝑑𝑇ℎ
𝑑𝑡
+
𝑑𝑅ℎ
𝑑𝑡
 while 
𝑑𝑁𝑣
𝑑𝑡
=
𝑑𝑆𝑣
𝑑𝑡
+
𝑑𝐼𝑣
𝑑𝑡
. 
From equations 2.1 to 2.7;  
 
𝑑𝑁ℎ
𝑑𝑡
= 𝛼ℎ − 𝜇ℎ𝑁ℎ − 𝛿ℎ𝐶ℎ − 𝛿ℎ𝐼ℎ − (1 − 𝛽)𝛿ℎ𝑇ℎ 
 
 
𝑑𝑁ℎ
𝑑𝑡
≤ 𝛼ℎ − 𝜇ℎ𝑁ℎ (3.1) 
Similarly;  
 
𝑑𝑁𝑣
𝑑𝑡
= 𝛼𝑣 − 𝜇𝑣𝑁𝑣 − 𝛿𝑣𝐼𝑣  
 
 ≤ 𝛼𝑣 − 𝜇𝑣𝑁𝑣 (3.2) 
Integrating both sides of (3.1), we have;  
 ∫
𝑑𝑁ℎ
𝛼ℎ−𝜇ℎ𝑁ℎ
≤ ∫ 𝑑𝑡 
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−1
𝜇ℎ
ln(𝛼ℎ − 𝜇ℎ𝑁ℎ) ≤ 𝑡 + 𝐶 
where C is a constant of integration. 
Thus,  
 ln(𝛼ℎ − 𝜇ℎ𝑁ℎ) ≥ −(𝜇ℎ𝑡 + 𝐶) 
 
 (𝛼ℎ − 𝜇ℎ𝑁ℎ) ≥ 𝐴𝑒
−𝜇ℎ𝑡 
where A is a constant of integration. Let 𝑁ℎ(0) = 𝑁0, then;  
 (𝛼ℎ − 𝜇ℎ𝑁0) ≥ 𝐴 
Accordingly,  
 (𝛼ℎ − 𝜇ℎ𝑁ℎ) ≥ (𝛼ℎ − 𝜇ℎ𝑁0)𝑒
−𝜇ℎ𝑡 
 
 𝑁ℎ(𝑡) ≤
𝛼ℎ
𝜇ℎ
−
(𝛼ℎ−𝜇ℎ𝑁0)
𝜇ℎ
𝑒−𝜇ℎ𝑡 
 
 𝑁ℎ(𝑡) →
𝛼ℎ
𝜇ℎ
    𝑎𝑠    𝑡 → ∞ 
Thus, 𝑁ℎ(𝑡) ∈ [0,
𝛼ℎ
𝜇ℎ
]. 
Similarly, solving (3.2), we obtain; 𝑁𝑣(𝑡) ∈ [0,
𝛼𝑣
𝜇𝑣
]. 
Hence, the feasible set of the solution of the model equations enter and remain in the invariant region:  
 Ω = {(𝑆ℎ , 𝐶ℎ, 𝐼ℎ , 𝑇ℎ, 𝑅ℎ) ∈ 𝑅+
5     𝑈    (𝑆𝑣 , 𝐼𝑣) ∈ 𝑅+
2 : 𝑁ℎ(𝑡) ≤
𝛼ℎ
𝜇ℎ
, 𝑁𝑣(𝑡) ≤
𝛼𝑣
𝜇𝑣
} (3.3) 
 
3.2 Positivity of the Solution 
The Positivity Theorem: 
Let Ω1 = {(𝑆ℎ , 𝐶ℎ, 𝐼ℎ , 𝑇ℎ, 𝑅ℎ) ∈ 𝑅+
5 : 𝑆0 > 0, 𝐶0 > 0, 𝐼0 > 0, 𝑇0 > 0, 𝑅0 > 0}  and Ω2 = {(𝑆𝑣 , 𝐼𝑣) ∈ 𝑅+
2 : 𝑆0 >
0, 𝐼0 > 0}, then the solution of {𝑆ℎ, 𝐶ℎ, 𝐼ℎ , 𝑇ℎ , 𝑅ℎ, 𝑆𝑣 , 𝐼𝑣} are positive for 𝑡 ≥ 0. Proof: 
Considering equation 2.1,  
 
𝑑𝑆ℎ
𝑑𝑡
= 𝛼ℎ +𝜔ℎ𝑅ℎ − (𝛽𝑐𝐶ℎ + 𝛽ℎ𝐼ℎ + 𝛽𝑣𝐼𝑣)𝑆ℎ − 𝜇ℎ𝑆ℎ 
 
 ≥ −(𝛽𝑐𝐶ℎ + 𝛽ℎ𝐼ℎ + 𝛽𝑣𝐼𝑣 + 𝜇ℎ)𝑆ℎ 
thus,  
 ∫
𝑑𝑆ℎ
𝑆ℎ
≥ −∫ (𝛽𝑐𝐶ℎ + 𝛽ℎ𝐼ℎ + 𝛽𝑣𝐼𝑣 + 𝜇ℎ)𝑑𝑡 
 
 ln𝑆ℎ(𝑡) ≥ −𝐴(𝑡) + 𝐶 
 
 𝑆ℎ(𝑡) ≥ 𝐵𝑒
−𝐴(𝑡) 
Where 𝐴(𝑡) = ∫ (𝛽𝑐𝐶ℎ + 𝛽ℎ𝐼ℎ + 𝛽𝑣𝐼𝑣 + 𝜇ℎ)𝑑𝑡 and C is a constant of integration. 
At 𝑡 = 0, 𝑆0 > 0𝐵 = 𝑒
𝐶 ≥ 0 
Accordingly;  
 𝑆ℎ(𝑡) ≥ 𝑆0𝑒
−𝐴(𝑡) ≥ 0    ∀    𝑡 ≥ 0 (3.4) 
Similarly, considering equation 2.2,  
 
𝑑𝐶ℎ
𝑑𝑡
= (𝛽𝑐𝐶ℎ + 𝛽ℎ𝐼ℎ + 𝛽𝑣𝐼𝑣)𝑆ℎ − 𝜎ℎ𝐶ℎ − 𝛾1𝐶ℎ − 𝛿ℎ𝐶ℎ − 𝜇ℎ𝐶ℎ 
 
 ≥ −(𝜎ℎ + 𝛾1 + 𝛿ℎ + 𝜇ℎ)𝐶ℎ 
Thus,  
 ∫
𝑑𝐶ℎ
𝐶ℎ
≥ −∫ (𝜎ℎ + 𝛾1 + 𝛿ℎ + 𝜇ℎ)𝑑𝑡 
 
 𝑙𝑛𝐶ℎ(𝑡) ≥ −(𝜎ℎ + 𝛾1 + 𝛿ℎ + 𝜇ℎ)𝑡 + 𝐷 
Where D is a constant of integration.  
 𝐶ℎ(𝑡) ≥ 𝐵𝑒
−𝐴𝑡 
Where 𝐴 = (𝜎ℎ + 𝛾1 + 𝛿ℎ + 𝜇ℎ) ≥ 0 
At 𝑡 = 0, 𝐶0 > 0𝐵 = 𝑒
𝐷 ≥ 0 
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Accordingly;  
 𝐶ℎ(𝑡) ≥ 𝐶0𝑒
−𝐴𝑡 ≥ 0    ∀    𝑡 ≥ 0 (3.5) 
Next, considering equation 2.3,  
 
𝑑𝐼ℎ
𝑑𝑡
= 𝜎ℎ𝐶ℎ − 𝛾2𝐼ℎ − 𝛾4𝐼ℎ − 𝛿ℎ𝐼ℎ − 𝜇ℎ𝐼ℎ 
 
 ≥ −(𝛾2 + 𝛾4 + 𝛿ℎ + 𝜇ℎ)𝐼ℎ 
Hence,  
 𝐼ℎ(𝑡) ≥ 𝐼0𝑒
−𝐴𝑡 ≥ 0    ∀    𝑡 ≥ 0 (3.6) 
Where 𝐴 = (𝛾2 + 𝛾4 + 𝛿ℎ + 𝜇ℎ) ≥ 0 
In the same way, considering equation 2.4 we have;  
 𝑇ℎ(𝑡) ≥ 𝑇0𝑒
−𝐴𝑡 ≥ 0    ∀    𝑡 ≥ 0 (3.7) 
Where 𝐴 = (𝛽𝛾3 + (1 − 𝛽)𝛿ℎ + 𝜇ℎ) ≥ 0 
and considering equation 2.5, we have;  
 𝑅ℎ(𝑡) ≥ 𝑅0𝑒
−𝐴𝑡 ≥ 0    ∀    𝑡 ≥ 0 (3.8) 
where 𝐴 = (𝜔ℎ + 𝜇ℎ) ≥ 0 
Next, considering equation 2.6, we obtain;  
 𝑆𝑣(𝑡) ≥ 𝑆0𝑒
−𝐴𝑡 ≥ 0    ∀    𝑡 ≥ 0 (3.9) 
where 𝐴 = (𝜔𝑣 + 𝜇𝑣) ≥ 0 
and lastly, considering equation 2.7, we obtain;  
 𝐼𝑣(𝑡) ≥ 𝐼0𝑒
−𝐴𝑡 ≥ 0    ∀    𝑡 ≥ 0 (3.10) 
where 𝐴 = (𝜇𝑣 + 𝛿𝑣) ≥ 0 
This completes the proof of the theorem. 
 
3.3 The Equilibrium Points 
3.3.1 The Disease Free Equilibrium Point (DFE): 
The DFE of the model is defined as (𝑆ℎ
∗(𝑡),0,0,0,0, 𝑆𝑣
∗(𝑡),0) satisfying; 
𝑑𝑆ℎ
𝑑𝑡
=
𝑑𝐶ℎ
𝑑𝑡
=
𝑑𝐼ℎ
𝑑𝑡
=
𝑑𝑇ℎ
𝑑𝑡
=
𝑑𝑅ℎ
𝑑𝑡
= 0 and 
𝑑𝑆𝑣
𝑑𝑡
=
𝑑𝐼𝑣
𝑑𝑡
= 0 and 
𝑑𝑆𝑣
𝑑𝑡
=
𝑑𝐼𝑣
𝑑𝑡
= 0 
By equating equations (2.1) to (2.7) to 0 and substituting 𝐶ℎ = 𝐼ℎ = 𝑇ℎ = 𝑅ℎ = 𝐼𝑣 = 0, We obtain 𝑆ℎ
∗ =
𝛼ℎ
𝜇ℎ
. 
Accordingly, the DFE is obtained as:  
 𝐸0 = (
𝛼ℎ
𝜇ℎ
, 0,0,0,0) (3.11) 
 
3.3.2 The Endemic Equilibrium Point 
The EEP of the model is defined as (𝑆ℎ
∗(𝑡), 𝐶ℎ
∗(𝑡), 𝐼ℎ
∗(𝑡), 𝑇ℎ
∗(𝑡), 𝑅ℎ
∗(𝑡), 𝑆𝑣
∗(𝑡), 𝐼𝑣
∗(𝑡)) satisfying; 
𝑑𝑆ℎ
𝑑𝑡
=
𝑑𝐶ℎ
𝑑𝑡
=
𝑑𝐼ℎ
𝑑𝑡
=
𝑑𝑇ℎ
𝑑𝑡
=
𝑑𝑅ℎ
𝑑𝑡
= 0 and 
𝑑𝑆𝑣
𝑑𝑡
=
𝑑𝐼𝑣
𝑑𝑡
= 0 
Solving 
𝑑𝑆𝑣
𝑑𝑡
=
𝑑𝐼𝑣
𝑑𝑡
= 0, we obtain; 
𝛼𝑣 − (𝜔𝑣 + 𝜇𝑣)𝑆𝑣 = 0  and  𝜔𝑣𝑆𝑣 − (𝜇𝑣 + 𝛿𝑣)𝐼𝑣 = 0 
which yields:  
 𝑆𝑣
∗ =
𝛼𝑣
(𝜔𝑣+𝜇𝑣)
 (3.12) 
and  
 𝐼𝑣
∗ =
𝜔𝑣𝛼𝑣
(𝜇𝑣+𝛿𝑣)(𝜔𝑣+𝜇𝑣)
 (3.13) 
Next, equating equation (2.3) to 0, we obtain:  
 𝐼ℎ
∗ =
𝜎ℎ𝐶ℎ
∗
𝐴
 (3.14) 
where 𝐴 = 𝛾2 + 𝛾4 + 𝛿ℎ + 𝜇ℎ 
Similarly, equating equation (2.4) to 0, we obtain:  
 𝑇ℎ
∗ =
𝛾2𝐼ℎ
∗
𝐵
 
 
 =
𝛾2𝜎ℎ𝐶ℎ
∗
𝐴𝐵
 (3.15) 
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where 𝐵 = 𝛽𝛾3 + (1 − 𝛽)𝛿ℎ + 𝜇ℎ 
Similarly, equating equation (2.5) to 0, we obtain:  
 𝑅ℎ
∗ =
𝛾1𝐶ℎ
∗+𝛾4𝐼ℎ
∗+𝛽𝛾3𝑇𝐻
∗
𝐶
 
 
 =
𝐷𝐶ℎ
∗
𝐴𝐵𝐶
 (3.16) 
where 𝐶 = 𝜔ℎ + 𝜇ℎ  and  𝐷 = 𝐴𝐵𝛾1 + 𝐵𝛾4𝜎ℎ + 𝛽𝛾2𝛾3𝜎ℎ 
Now, adding equations (2.1) to (2.5) at 
𝑑𝑆ℎ
𝑑𝑡
=
𝑑𝐶ℎ
𝑑𝑡
=
𝑑𝐼ℎ
𝑑𝑡
=
𝑑𝑇ℎ
𝑑𝑡
=
𝑑𝑅ℎ
𝑑𝑡
= 0, we have;  
 𝛼ℎ − 𝜇ℎ𝑆ℎ
∗ − (𝛿ℎ + 𝜇ℎ)𝐶ℎ
∗ − (𝛿ℎ + 𝜇ℎ)𝐼ℎ
∗ − ((1 − 𝛽)𝛿ℎ + 𝜇ℎ)𝑇ℎ
∗ − 𝜇ℎ𝑅ℎ
∗ = 0 (3.17) 
which yields:  
 𝛼ℎ − 𝜇ℎ𝑆ℎ
∗ − (𝛿ℎ + 𝜇ℎ)𝐶ℎ
∗ − (𝛿ℎ + 𝜇ℎ)
𝜎ℎ𝐶ℎ
∗
𝐴
− (𝑏𝛿ℎ + 𝜇ℎ)
𝛾2𝜎ℎ𝐶ℎ
∗
𝐴𝐵
− 𝜇ℎ
𝐷𝐶ℎ
∗
𝐴𝐵𝐶
= 0 
where 𝑏 = (1 − 𝛽) 
Accordingly;  
 𝛼ℎ − 𝜇ℎ𝑆ℎ
∗ −
𝐸𝐶ℎ
∗
𝐴𝐵𝐶
= 0 
where 𝐸 = 𝐷𝜇ℎ + (𝑏𝛿ℎ + 𝜇ℎ)𝛾2𝜎ℎ𝐶 + (𝛿ℎ + 𝜇ℎ)𝜎ℎ𝐵𝐶 + (𝛿ℎ + 𝜇ℎ)𝐴𝐵𝐶 
Thus:  
 𝐶ℎ
∗ =
𝐴𝐵𝐶
𝐸
(𝛼ℎ − 𝜇ℎ𝑆ℎ
∗) (3.18) 
Substituting equation (3.18) into equations (3.14) to (3.16), we obtain:  
 𝐼ℎ
∗ =
𝜎ℎ𝐵𝐶
𝐸
(𝛼ℎ − 𝜇ℎ𝑆ℎ
∗) (3.19) 
 𝑇ℎ
∗ =
𝛾2𝜎ℎ𝐶
𝐸
(𝛼ℎ − 𝜇ℎ𝑆ℎ
∗) (3.20) 
 𝑅ℎ
∗ =
𝐷
𝐸
(𝛼ℎ − 𝜇ℎ𝑆ℎ
∗) (3.21) 
 
Clearly, all the state variables, (𝑆ℎ
∗, 𝐶ℎ
∗, 𝐼ℎ
∗, 𝑇ℎ
∗, 𝑅ℎ
∗ , 𝑆𝑣
∗, 𝐼𝑣
∗), are strictly positive since (𝛼ℎ − 𝜇ℎ𝑆ℎ
∗) ≥ 0 and in fact 
(𝛼ℎ − 𝜇ℎ𝑆ℎ
∗) = 0 only at the DFE. 
Hence there exist an EEP, 𝐸∗ = (𝑆ℎ
∗(𝑡), 𝐶ℎ
∗(𝑡), 𝐼ℎ
∗(𝑡), 𝑇ℎ
∗(𝑡), 𝑅ℎ
∗(𝑡), 𝑆𝑣
∗(𝑡), 𝐼𝑣
∗(𝑡)). 
 
3.4 Local Asymptotic Stability Analysis 
The Basic Reproduction Number: 
According to the principle of next generation matrix, the basic reproduction number is the spectral radius of the 
next generation matrix 𝐹𝑉−1 of the system (2.1) to (2.7). Where:  
 𝑓𝑖 − 𝑣𝑖 = (
𝐶ℎ′
𝐼ℎ′
𝑇ℎ′
) 
 
 = (
(𝛽𝑐𝐶ℎ + 𝛽ℎ𝐼ℎ + 𝛽𝑣𝐼𝑣)𝑆ℎ − (𝜎ℎ + 𝛾1 + 𝛿ℎ + 𝜇ℎ)𝐶ℎ
𝜎ℎ𝐶ℎ − (𝛾2 + 𝛾4 + 𝛿ℎ + 𝜇ℎ)𝐼ℎ
𝛾2𝐼ℎ − (𝛽𝛾3 + (1 − 𝛽)𝛿ℎ + 𝜇ℎ)𝑇ℎ
) (3.22) 
 Accordingly;  
 𝑓𝑖 = (
(𝛽𝑐𝐶ℎ + 𝛽ℎ𝐼ℎ + 𝛽𝑣𝐼𝑣)𝑆ℎ
                      0
                      0
) (3.23) 
 And;  
 𝑣𝑖 = (
(𝜎ℎ + 𝛾1 + 𝛿ℎ + 𝜇ℎ)𝐶ℎ
(𝛾2 + 𝛾4 + 𝛿ℎ + 𝜇ℎ)𝐼ℎ − 𝜎ℎ𝐶ℎ
(𝛽𝛾3 + (1 − 𝛽)𝛿ℎ + 𝜇ℎ)𝑇ℎ − 𝛾2𝐼ℎ
) (3.24) 
where 𝑓𝑖 is the rate of appearance of new infection(s) in compartment i and 𝑣𝑖 represents the rate of transfer of 
individuals into compartment i, with 𝑖 ∈ [1,3]. 
The matrix F and V are obtained as follows:  
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 𝐹 =
(
 
 
 
𝜕𝑓1
𝜕𝐶ℎ
𝜕𝑓1
𝜕𝐼ℎ
𝜕𝑓1
𝜕𝑇ℎ
𝜕𝑓2
𝜕𝐶ℎ
𝜕𝑓2
𝜕𝐼ℎ
𝜕𝑓2
𝜕𝑇ℎ
𝜕𝑓3
𝜕𝐶ℎ
𝜕𝑓3
𝜕𝐼ℎ
𝜕𝑓3
𝜕𝑇ℎ
)
 
 
 
 
 
 = (
𝛽𝑐𝑆ℎ 𝛽ℎ𝑆ℎ 0
0 0 0
0 0 0
) (3.25) 
 and;  
 𝑉 =
(
 
 
𝜕𝑣1
𝜕𝐶ℎ
𝜕𝑣1
𝜕𝐼ℎ
𝜕𝑣1
𝜕𝑇ℎ
𝜕𝑣2
𝜕𝐶ℎ
𝜕𝑣2
𝜕𝐼ℎ
𝜕𝑣2
𝜕𝑇ℎ
𝜕𝑣3
𝜕𝐶ℎ
𝜕𝑣3
𝜕𝐼ℎ
𝜕𝑣3
𝜕𝑇ℎ)
 
 
 
 
 = (
(𝜎ℎ + 𝛾1 + 𝛿ℎ + 𝜇ℎ) 0 0
−𝜎ℎ (𝛾2 + 𝛾4 + 𝛿ℎ + 𝜇ℎ) 0
0 −𝛾2 (𝛽𝛾3 + (1 − 𝛽)𝛿ℎ + 𝜇ℎ)
) (3.26) 
  
Lastly, 𝑉−1  
(
 
 
1
𝛿ℎ+𝛾1+𝜇ℎ+𝜎ℎ
0 0
𝜎ℎ
(𝛿ℎ+𝛾1+𝜇ℎ+𝜎ℎ)(𝛿ℎ+𝛾2+𝛾4+𝜇ℎ)
1
𝛿ℎ+𝛾2+𝛾4+𝜇ℎ
0
−
𝛾2𝜎ℎ
((𝛽−1)𝛿ℎ−𝛽𝛾3−𝜇ℎ)(𝛿ℎ+𝛾1+𝜇ℎ+𝜎ℎ)(𝛿ℎ+𝛾2+𝛾4+𝜇ℎ)
−
𝛾2
((𝛽−1)𝛿ℎ−𝛽𝛾3−𝜇ℎ)(𝛿ℎ+𝛾2+𝛾4+𝜇ℎ)
−
1
(𝛽−1)𝛿ℎ−𝛽𝛾3−𝜇ℎ)
 
 
 
 
Thus, the next generation matrix:  
 𝐺 = 𝐹𝑉−1 
 
 = (
𝑆ℎ𝛽𝑐
𝛿ℎ+𝛾1+𝜇ℎ+𝜎ℎ
+
𝑆ℎ𝛽ℎ𝜎ℎ
(𝛿ℎ+𝛾1+𝜇ℎ+𝜎ℎ)(𝛿ℎ+𝛾2+𝛾4+𝜇ℎ)
𝑆ℎ𝛽ℎ
𝛿ℎ+𝛾2+𝛾4+𝜇ℎ
0
0 0 0
0 0 0
) (3.27) 
 
The eigenvalues of the Matrix, G, are:  
 [
𝑆ℎ𝛽𝑐𝛿ℎ+𝑆ℎ𝛽𝑐𝛾2+𝑆ℎ𝛽𝑐𝛾4+𝑆ℎ𝛽𝑐𝜇ℎ+𝑆ℎ𝛽ℎ𝜎ℎ
𝛿ℎ
2+𝛿ℎ𝛾1+(𝛿ℎ+𝛾1)𝛾2+(𝛿ℎ+𝛾1)𝛾4+(2 𝛿ℎ+𝛾1+𝛾2+𝛾4)𝜇ℎ+𝜇ℎ
2+(𝛿ℎ+𝛾2+𝛾4+𝜇ℎ)𝜎ℎ
, 0,0] 
 
 = [
𝑆ℎ
∗𝛽𝑐
(𝛿ℎ+𝛾1+𝜇ℎ+𝜎ℎ)
+
𝑆ℎ
∗𝛽ℎ𝜎ℎ
(𝛿ℎ+𝛾1+𝜇ℎ+𝜎ℎ)(𝛿ℎ+𝛾2+𝛾4+𝜇ℎ)
, 0,0] (3.28) 
 
Hence, the spectral radius of G is;  
 𝑅0 = 𝑅1 + 𝑅2 =
𝛼ℎ𝛽𝑐
𝜇ℎ(𝛿ℎ+𝛾1+𝜇ℎ+𝜎ℎ)
+
𝛼ℎ𝛽ℎ𝜎ℎ
𝜇ℎ(𝛿ℎ+𝛾2+𝛾4+𝜇ℎ)(𝛿ℎ+𝛾1+𝜇ℎ+𝜎ℎ)
 
 
 =
(𝛽𝑐𝛿ℎ+𝛽𝑐𝛾2+𝛽𝑐𝛾4+𝛽𝑐𝜇ℎ+𝛽ℎ𝜎ℎ)𝑆ℎ
∗
𝛿ℎ
2+𝛿ℎ𝛾1+(𝛿ℎ+𝛾1)𝛾2+(𝛿ℎ+𝛾1)𝛾4+(2 𝛿ℎ+𝛾1+𝛾2+𝛾4)𝜇ℎ+𝜇ℎ
2+(𝛿ℎ+𝛾2+𝛾4+𝜇ℎ)𝜎ℎ
 (3.29) 
 
Accordingly, by substituting the values in table (3.1) below the basic reproduction number is obtained as;  
 𝑅0 = 0.46252994 (3.30) 
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Table  3.1: Table of Values 
 
 
 Parameters  
 
     Values  
 
        Sources  
𝛼ℎ     0.0915  Estimate  
𝜇ℎ     0.0000548  [3]  
𝜔ℎ     0.25   Estimate  
𝛽𝑐     0.000062   [15]  
𝛽ℎ     0.00012   Estimate  
𝛽𝑣     0.005   [3]  
𝛿ℎ     0.001   [9]  
𝜇𝑣     0.000167   Estimate  
𝜎ℎ     0.50   [17] 
𝛾2     0.70   Estimate  
𝛼𝑣   0.70   [5]  
𝛿𝑣   0.05   Estimate  
𝜔𝑣   0.02   Estimate  
𝛾3   0.50   [17]  
𝛾1   0.0315   Estimate  
𝛾4   0.0005   Estimate  
𝛽   0.45   Estimate  
 
  
The Principle of Next Generation Matrix: 
The DFE of an infectious disease is LAS if the basic reproduction number, 𝑅0 < 1 and the EEP, if it exist, is 
unstable. 
Proof: 
Applying the Routh-Hurwitz Stability Criterion, the Jacobian matrix of the system (2.1) to (2.7) at the DFE point, 
(𝑆ℎ
∗, 0,0,0,0, 𝑆𝑣
∗, 0), is given as:  
 
 
 
 
 
The eigenvalues of the Jacobian matrix, J, are :  
 𝜆1,2 = (
𝛼ℎ𝛽𝑐−(2 𝛿ℎ+𝛾1+𝛾2+𝛾4)𝜇ℎ−2 𝜇ℎ
2−𝜇ℎ𝜎ℎ±√𝑍
2 𝜇ℎ
) 
𝜆3 = −(𝜇𝑣 + 𝜔𝑣), 𝜆4 = −(𝜇ℎ + 𝜔ℎ), 𝜆5 = −(𝛿𝑣 + 𝜇𝑣), 𝜆6 = −(1 − 𝛽)𝛿ℎ + 𝛽𝛾3 + 𝜇ℎ and 𝜆7 = −𝜇ℎ. 
where; 
𝑍 = 𝛼ℎ
2𝛽𝑐
2 + 𝜇ℎ
2𝜎ℎ
2 + (𝛾1
2 − 2 𝛾1𝛾2 + 𝛾2
2 − 2 (𝛾1 − 𝛾2)𝛾4 + 𝛾4
2)𝜇ℎ
2 − 2 (𝛼ℎ𝛽𝑐𝛾1 − 𝛼ℎ𝛽𝑐𝛾2 − 𝛼ℎ𝛽𝑐𝛾4)𝜇ℎ
+ 2 ((𝛾1 − 𝛾2 − 𝛾4)𝜇ℎ
2 − (𝛼ℎ𝛽𝑐 − 2 𝛼ℎ𝛽ℎ)𝜇ℎ)𝜎ℎ 
Clearly, all the eigenvalues of the Jacobian matrix are strictly negative provided: 
(
𝛼ℎ𝛽𝑐−(2 𝛿ℎ+𝛾1+𝛾2+𝛾4)𝜇ℎ−2 𝜇ℎ
2−𝜇ℎ𝜎ℎ+√𝑍
2 𝜇ℎ
) < 0. Thus, it follows that if 𝑅0 as defined in equation (3.29) is 
less than unity, then the DFE is locally asymptotically stable. 
Accordingly, since the threshold parameter 𝑅0 = 0.46252994 < 1, then the DFE is LAS and the EEP is unstable, 
hence the disease cannot invade the population. However, the existence of the Endemic equilibria implies that the 
disease may persist in the population. 
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3.5 Global Asymptotic Stability Analysis 
In order to examine the DFE for global stability, we shall employ the procedure implemented by [8]. We shall 
denote the Lassa fever model by:  
 (
𝑑𝑋
𝑑𝑡
= 𝐹(𝑋, 𝑌)
𝑑𝑌
𝑑𝑡
= 𝐺(𝑋, 𝑌)
 (3.31) 
where 𝑋 = (𝑆ℎ , 𝑅ℎ, 𝑆𝑣)  denotes the uninfected population and 𝑌 = (𝐶ℎ , 𝐼ℎ , 𝑇ℎ , 𝐼𝑣)  denotes the Infected 
population. 
The point 𝐸0 = (𝑋
∗, 0) is said to be globally asymptotically stable if 𝑅0 < 1 and in addition the following two 
conditions hold: 
C1: For 
𝑑𝑋
𝑑𝑡
= 𝐹(𝑋, 0) , 𝐸0 is globally asymptotically stable. 
C2: 𝐺(𝑋, 𝑌) = 𝐴𝑌 − 𝐺∗(𝑋, 𝑌) , 𝐺∗(𝑋, 𝑌) ≥ 0 for (𝑋, 𝑌) ∈ Ω 
For C1:  
 𝐹(𝑋, 0) = (
𝛼ℎ + 𝜔ℎ𝑅ℎ − 𝜇ℎ𝑆ℎ
−(𝜔ℎ + 𝜇ℎ)𝑅ℎ
𝛼𝑣 − (𝜔𝑣 + 𝜇𝑣)𝑆𝑣
 (3.32) 
Clearly, 𝐸0 = (
𝛼ℎ
𝜇ℎ
, 0,0,0,0,
𝛼𝑣
𝜇𝑣
, 0) is globally asymptotically stable for 
𝑑𝑋
𝑑𝑡
= 𝐹(𝑋, 0). This can be verified as 
shown below: By solving equation (3.32) using the method of integrating factor, we have: 
𝑑𝑆ℎ
𝑑𝑡
= 𝛼ℎ + 𝜔ℎ𝑅ℎ − 𝜇ℎ𝑆ℎ 
𝐼. 𝐹 = 𝑒∫𝜇ℎ𝑑𝑡 
(
𝑑𝑆ℎ
𝑑𝑡
+ 𝜇ℎ𝑆ℎ)𝑒
𝜇ℎ𝑡 = (𝛼ℎ − 𝜔ℎ𝑅ℎ)𝑒
𝜇ℎ𝑡 
𝑑
𝑑𝑡
(𝑆ℎ𝑒
𝜇ℎ𝑡) = (𝛼ℎ − 𝜔ℎ𝑅ℎ)𝑒
𝜇ℎ𝑡 
Thus, 𝑆ℎ =
𝛼ℎ
𝜇ℎ
−
1
𝑒𝜇ℎ𝑡
∫ 𝜔ℎ𝑅ℎ𝑒
𝜇ℎ𝑡𝑑𝑡 
accordingly, 𝑆ℎ(𝑡) →
𝛼ℎ
𝜇ℎ
 as 𝑡 → ∞ 
Similarly, 𝑆𝑣(𝑡) →
𝛼𝑣
𝜇𝑣
 as 𝑡 → ∞ 
which implies the global convergence of 3.32 in Ω. 
For C2: 
 
 𝐺(𝑋, 𝑌) = (
(𝛽𝑐𝐶ℎ + 𝛽ℎ𝐼ℎ + 𝛽𝑣𝐼𝑣)𝑆ℎ − (𝜎ℎ + 𝛾1 + 𝛿ℎ + 𝜇ℎ)𝐶ℎ
𝜎ℎ𝐶ℎ − (𝛾2 + 𝛾4 + 𝛿ℎ + 𝜇ℎ)𝐼ℎ
𝛾2𝐼ℎ − (𝛽𝛾3 + 𝑏𝛿ℎ + 𝜇ℎ)𝑇ℎ
𝜔𝑣𝑆𝑣 − (𝜇𝑣 + 𝛿𝑣)𝐼𝑣
 (3.33) 
  
 = 𝐴𝑌 − 𝐺∗(𝑋, 𝑌) 
Where:  
 𝐴 =
(
 
 
−(𝜎ℎ + 𝛾1 + 𝛿ℎ + 𝜇ℎ) 0 0 0
𝜎ℎ −(𝛾2 + 𝛾4 + 𝛿ℎ + 𝜇ℎ) 0 0
0 𝛾2 −(𝛽𝛾3 + 𝑏𝛿ℎ + 𝜇ℎ) 0
0 0 0 −(𝜇𝑣 + 𝛿𝑣) )
 
 
 
  
and;  
 𝐺∗(𝑋, 𝑌) = [
−(𝛽𝑐𝐶ℎ + 𝛽ℎ𝐼ℎ + 𝛽𝑣𝐼𝑣)𝑆ℎ
0
0
−𝜔𝑣𝑆𝑣
] 
 Clearly, 𝐺∗(𝑋, 𝑌) ≤ 0. Hence, condition 2 is not satisfied. Thus, 𝐸0 = (𝑋
∗, 0) may not be GAS for 𝑅0 < 1.  
 
Mathematical Theory and Modeling                                                                                           www.iiste.org 
ISSN 2224-5804 (Paper)    ISSN 2225-0522 (Online) DOI: 10.7176/MTM 
Vol.9, No.6, 2019 
 
56 
 
4. Numerical Simulations and Discussion of Results 
In order to solve the model equations numerically, we implemented the MATLAB ODE45 algorithm for the 
developed model, and plotted the graphs of each model compartment against time, with time ranging from 0 to 
150 days, we obtained the following results: 
 
4.1 Susceptible Human Population 
Figure 4.1 indicates that the susceptible human population decreases rapidly within the first few days due to the 
awareness/sensitivity of the affected population towards the infection and also because of the progression from the 
susceptible class to the carrier class. However, after these few days, an inflexion point is reached and then the 
population begins to increase steadily for the remaining 100 days due to the loss of immunity of the recovered 
human population. This result is in agreement with the results of [20] and [6]. It can be observed that an increase 
in the contracting rate of the susceptible class via contact with the carrier class, 𝛽𝑐, leads to a decrease in the 
population of this compartment. 
   
 
Figure  4.1: Graph of the Susceptible Human Population against Time varying 𝛽𝑐 
 
 
4.2 Carrier Human Population 
In figure 4.2 to 4.4, the introduced carrier compartment reduces drastically in size from 40 to 19 during the first 5 
days. This is unsurprisingly due to the progression of the carriers to the infected compartment since the incubation 
period of the disease is relatively short (6 to 21 days) and also due to the disease-induced death of the class. 
Thereafter, the compartment begins to increase in its population from 19 to 25 within a duration of 20 days due to 
the inflow from the susceptible compartment. Subsequently, the population was maintained at 25 due to the balance 
achieved in the inflow and outflow of humans in this compartment. It can be observed that an increase in the rate 
of recovery of the Carrier class, 𝛾1 and the progression rate from the carrier class to the infected class, 𝜎ℎ, lead 
to a decrease in the population of the carrier class. Meanwhile an increase in the contracting rate of the susceptible 
class via contact with the carrier class, 𝛽𝑐, leads to an increase in the population of the carriers. 
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Figure  4.2: Graph of the Carrier Human Population against Time varying 𝛾1 
 
 
Figure  4.3: Graph of the Carrier Human Population against Time varying varying 𝛽 
    
 
Figure  4.4: Graph of the Carrier Human Population against Time varying varying 𝜎ℎ 
4.3 Infected Human Population 
From figure 4.5, the infected human population experiences a rapid decrease within the first 5 days. This decrease 
can be ascribed to the availability of treatment for the infected compartment since they are symptomatic and thus 
easily diagnosable compared to the carriers who are without symptom. After this period, however, there is a short 
increase in the population of this compartment because of the progression from the carrier compartment. 
Thereafter, the population of this compartment is maintained at a stable value of 17 because of the balance in the 
inflow and out flow of individuals within this population. This result is in slight contrast with those in previous 
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literatures. According to [3] and [20], the infected human compartment experiences a rapid increase between time 
0 and 5. This increase was ascribed to the progression from the susceptible human population to the infected human 
population. This, however, is not true in our case as there do not exist a progression into the infected human 
compartment directly from the susceptible human compartment. It can be observed that an increase in the 
progression rate from the carrier class to the infected class, 𝜎ℎ, lead to an increase in the population of the infected 
class. 
 
 
Figure  4.5: Graph of the Infected Human Population against Time varying 𝜎ℎ 
 
4.4 Treated Human Population 
Figure 4.6 shows that the treated human population increases rapidly within the first 0 days due to the progression 
from the infected class into this class. Thereafter, there exist little decrease in the population due to the recovery 
of the treated humans. 45 member of the treated human population was then maintained for the remaining period 
of the experiment due to the steady inflow and outflow within the population ascribed to the progression from the 
infected class and the progression into the recovered class respectively. This result is in sharp agreement with that 
of [3]. 
 
   
Figure 4.6: Graph of Treated Human Population against Time 
    
4.5 Recovered Human Population 
Figure 4.7 indicates that the recovered human compartment increases in size rapidly first a during the first 5 days 
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of the experiment due to its population by the treated humans who have recovered. Thereafter, there is a little 
decrease in this compartment ascribed to the progression of the recovered human population into the susceptible 
class due to loss of immunity. This decrease, however, does not last too long as the treated humans continues to 
move into the recovered class due to the efficacy of the treatment given. Hence, the recovered human population 
remains maintained at a stable state after the first 50 days. This result is in agreement with that of [3] but not with 
that of [4] since they did not consider immunity loss in their model construction. It can be observed that an increase 
in the rate of recovery of the Carrier class, 𝛾1 leads to an increase in the population of the recovered class. 
   
 
Figure  4.7: Graph of the Recovered Human Population against Time varying 𝛾1 
4.6 Susceptible Vector Population 
From figure 4.8, the susceptible vector population decreases steadily and continues to decrease for a long period 
of time due to the progression into the infected vector compartment. After this period, however, the susceptible 
compartment is maintained at a steady state since it was continually populated either by new births or by 
recruitments from outside the studied population. However, since there do not exist the use of Rodenticide, 
decrease in this compartment was only due to natural death or the progression into the infected compartment. This 
result is in slight disagreement with that of [3] and [4] since they considered Rodenticide factor in their model. The 
use of Rodenticide, however, shall be introduced as a control parameter during the formulation of the optimal 
control problem. 
 
 
Figure  4.8: Graph of the Susceptible Vector Population against Time 
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5.7 Infected Vector Population 
From figure 4.9, the infected vector population increases rapidly during the first 40 days due to its population by 
the susceptible vector population and thereafter decreases steadily due to the disease induced death rate and the 
natural death rate of the vectors. This decrease, however was not progressive since there was no use of Rodenticide 
nor was their recovery from the infectiousness. This is in contrast with the result of [3], in which there was a rapid 
decrease in this population due to the application of Rodenticide.  
 
 
Figure  4.9: Graph of the Infected Vector Population against Time 
    
 
5. Conclusion and Recommendations 
The results of the analyses of the developed model indicate that the disease free equilibrium of Lassa fever is stable 
while the endemic equilibrium point is unstable. These results imply that it is possible to stop the growth and 
spread of this disease within a studied population provided the assumptions and parameters of the developed model 
are implemented within such population including the isolation and treatment of the infected class. Similarly, from 
the simulation of the model, we observe that the carriers and infected class are maintained at a relatively low value 
by the end of the 150 observed days. However, the infected class is maintained at 17 which is relatively lower than 
the carrier class which was maintained at 29. This result is because of the availability of treatment for the infected 
class but not for the carrier class. 
Hence, an OCP model which takes into consideration early diagnosis/early treatment of the carrier class alongside 
other control parameters should be developed and an optimal control application should be made on such model. 
Also, sensitivity analyses should be performed on the developed model in order to see the specific effect of each 
parameter of the model on the spread and control of the disease. 
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